Modulation of the functional connectome in major depressive disorder by ketamine therapy Read More > December 3, 2020
Does body mass index predict response to intravenous ketamine treatment in adults with major depressive and bipolar disorder? Results from the Canadian Rapid Treatment Center of Excellence Read More > December 3, 2020
Post-Marketing Safety Concerns with Esketamine: A Disproportionality Analysis of Spontaneous Reports Submitted to the FDA Adverse Event Reporting System Read More > December 1, 2020
Hallucinogens in Mental Health: Preclinical and Clinical Studies on LSD, Psilocybin, MDMA, and Ketamine Read More > November 30, 2020
Combining Ketamine, Brain Stimulation (rTMS) and Mindfulness Therapy (TIMBER) for Opioid Addiction Read More > November 30, 2020
Is ketamine an appropriate alternative to ECT for patients with treatment resistant depression? A systematic review Read More > November 30, 2020
Corticosterone as a Potential Confounding Factor in Delineating Mechanisms Underlying Ketamine’s Rapid Antidepressant Actions Read More > November 30, 2020
Increased signal diversity/complexity of spontaneous EEG, but not evoked EEG responses, in ketamine-induced psychedelic state in humans Read More > November 23, 2020
The Effects of Ketamine on Cognition in Treatment-Resistant Depression: A Systematic Review and Priority Avenues for Future Research Read More > November 23, 2020
The time course of psychotic symptom side effects of ketamine in the treatment of depressive disorders: a systematic review and meta-analysis Read More > November 12, 2020
